ZeroStack (ZSTK)
Nasdaq Market Open
ZeroStack Corp. is a listed company that combines an AI-focused digital asset strategy with commercial and wholesale operating businesses. Its core investment focus is exposure to decentralised artificial intelligence, a developing area that sits at the intersection of blockchain networks, distributed computing, validator infrastructure, and AI-related data and processing demand.
The company pursues this theme through a concentrated digital asset approach. Its strategy is structured to generate yield and fee-based income from activities such as staking validators, exposure to compute power technology companies, and complementary businesses within the wider AI ecosystem. This places ZeroStack in a market where investors are increasingly looking at how decentralised networks may support AI workloads, data coordination, and computing resource marketplaces.
Alongside its digital asset and AI activities, ZeroStack operates a worldwide commercial and wholesale business through wholly owned subsidiaries. These operations include Phatebo and TruHC, which sell pharmaceutical products as well as a broader mix of consumer categories. The product range includes food and beverage, cannabis accessories and technology, and personal care and wellness items. This segment gives the company an operating business outside its digital asset strategy and may provide a different set of revenue drivers from its AI and blockchain-related activities.
ZeroStack’s profile is therefore distinct from a pure software, asset management, or cryptocurrency company. It combines exposure to decentralised AI and staking-related opportunities with wholesale distribution activities in health, wellness, and consumer products. Investors following ZSTK typically assess both the risks of digital asset markets and the execution of its commercial operating subsidiaries.
Last updated
- Market Cap
- $4,424,071
- P/E
- —
- P/FCF
- —
- P/S
- 0.15
- Enterprise Value
- $5,603,071
- Sector
- Health Care
- Industry
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Address
- 40 KING STREET WEST, TORONTO, M5H 3Y2
DeFi Development Q1 Earnings Call Highlights
ZeroStack Inks $107M Deal for 21% of 0G Token Supply
Nasdaq-Listed ZeroStack Corp. Makes $107 Million Institutional Commitment To Increase Strategic Position in 0G Token Ecosystem
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $4,424,071
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $5,603,071
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.12
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.15
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -0.96
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.19
- EPS
- -16.39
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -108.24%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -88.14%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.09
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.35
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.15
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.24
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $17,932
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 1.82
Income Statement
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Revenue | 35.68M | 35.87M | 76.07M | 33.4M | 8.98M |
| Cost of revenue | 34.03M | 33.67M | 58.33M | 20.15M | 6.56M |
| Gross profit | 1.65M | 2.2M | 17.74M | 13.25M | 2.43M |
| Operating income | -154.65M | -8.93M | -50.35M | -47.22M | -17.67M |
| EBITDA | -154.02M | -8.13M | -8.36M | -18.81M | -17.12M |
| Net income | -119.73M | -15.91M | -57.04M | -52.42M | -21.36M |
| Income taxes | 59K | 22K | -1.63M | -1.41M | -98K |
| Interest expense | — | — | -92K | 29K | -1.37M |
| Other operating expenses | 150.8M | 3.89M | 43.16M | 29.17M | 1.42M |
| Total operating expenses | 156.3M | 11.12M | 68.09M | 60.47M | 20.09M |
| Basic EPS | -43.49 | -50.02 | -302.25 | -533.52 | -374.4 |
| Diluted EPS | -43.49 | -50.02 | -302.25 | -533.52 | -374.4 |
Balance Sheet
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Total assets | 130.24M | 26.23M | 23.63M | 80.99M | 85.48M |
| Total liabilities | 59.68M | 21.72M | 17.22M | 24.58M | 8.54M |
| Total equity | 70.55M | 4.51M | 6.4M | 56.41M | 76.94M |
| Cash & equivalents | 5.6M | 5.22M | 4.35M | 8.94M | 37.61M |
| Current assets | 8.69M | 19.74M | 21.33M | 31.16M | 47.94M |
| Current liabilities | 8.63M | 14.61M | 16.28M | 17.15M | 6.12M |
| Accounts payable | 2.33M | 3.57M | 5.11M | 7.83M | 2.42M |
| Receivables | 799K | 5.81M | 7.1M | 8.96M | 5.6M |
| Inventories | 1.9M | 2.24M | 8.51M | 8.75M | 3.03M |
| Goodwill | — | — | — | 23.37M | 20.05M |
| Long-term debt | 50.77M | — | — | — | — |
Cash Flow
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Operating cash flow | -8.68M | -5.03M | -8.4M | -15.94M | -20.94M |
| Investing cash flow | -3.46M | 203K | -234K | -15.8M | -14.58M |
| Financing cash flow | 11.35M | 6.49M | 3.15M | 4.41M | 58.43M |
| Change in cash | 373K | 1.67M | -4.55M | -28.08M | 22.09M |
| Net income | -119.73M | -15.91M | -56.35M | -52.63M | -21.36M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 424B3 — ZeroStack Corp. | View Filing | |
| edgar index | EFFECT — ZeroStack Corp. | View Filing | |
| edgar index | S-4 — ZeroStack Corp. | View Filing | |
| edgar index | PRER14A — ZeroStack Corp. | View Filing | |
| edgar index | PRE 14A — ZeroStack Corp. | View Filing | |
| edgar index | ARS — ZeroStack Corp. | View Filing | |
| edgar index | 4 — ZeroStack Corp. | View Filing | |
| edgar index | 4 — ZeroStack Corp. | View Filing | |
| edgar index | 4 — ZeroStack Corp. | View Filing | |
| edgar index | 8-K — ZeroStack Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — LEVENTHAL MANFRED | View Filing | |
| form 4 | Form 4 — WOO EDWARD | View Filing | |
| form 4 | Form 4 — Zeifman Laurence | View Filing | |
| edgar index | 10-Q — ZeroStack Corp. | View Filing | |
| edgar index | 4 — ZeroStack Corp. | View Filing | |
| edgar index | SCHEDULE 13D/A — ZeroStack Corp. | View Filing | |
| edgar index | 8-K — ZeroStack Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Heinrich Michael | View Filing | |
| edgar index | 10-K — ZeroStack Corp. | View Filing | |
| edgar index | 8-K — ZeroStack Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | UPLOAD — ZeroStack Corp. | View Filing | |
| edgar index | 424B3 — Flora Growth Corp. | View Filing | |
| edgar index | FWP — Flora Growth Corp. | View Filing | |
| edgar index | 424B5 — Flora Growth Corp. | View Filing | |
| edgar index | EFFECT — Flora Growth Corp. | View Filing | |
| edgar index | CORRESP — Flora Growth Corp. | View Filing | |
| edgar index | 3 — Flora Growth Corp. | View Filing | |
| edgar index | S-3 — Flora Growth Corp. | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13D/A — Flora Growth Corp. | View Filing | |
| edgar index | SCHEDULE 13D/A — Flora Growth Corp. | View Filing | |
| edgar index | SCHEDULE 13D/A — Flora Growth Corp. | View Filing | |
| edgar index | S-8 — Flora Growth Corp. | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Flora Growth Corp. | View Filing | |
| edgar index | 4 — Flora Growth Corp. | View Filing | |
| edgar index | 4 — Flora Growth Corp. | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Heinrich Michael | View Filing | |
| form 4 | Form 4 — Reis-Faria Daniel | View Filing | |
| form 4 | Form 4 — Vaiman Dany | View Filing | |
| edgar index | EFFECT — Flora Growth Corp. | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| edgar index | S-1 — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | S-8 — Flora Growth Corp. | View Filing | |
| edgar index | 10-Q — Flora Growth Corp. | View Filing | |
| edgar index | DEF 14A — Flora Growth Corp. | View Filing | |
| edgar index | SCHEDULE 13D — Flora Growth Corp. | View Filing | |
| edgar index | 4 — Flora Growth Corp. | View Filing | |
| edgar index | PRE 14A — Flora Growth Corp. | View Filing | |
| edgar index | 4 — Flora Growth Corp. | View Filing | |
| form 4 | Form 4 — Heinrich Michael | View Filing | |
| edgar index | 3 — Flora Growth Corp. | View Filing | |
| form 4 | Form 4 — BROWN MICHAEL JOHN | View Filing | |
| edgar index | D — Flora Growth Corp. | View Filing | |
| edgar index | D — Flora Growth Corp. | View Filing | |
| edgar index | 4 — Flora Growth Corp. | View Filing | |
| edgar index | SCHEDULE 13D — Flora Growth Corp. | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Reis-Faria Daniel | View Filing | |
| edgar index | 3 — Flora Growth Corp. | View Filing | |
| edgar index | 424B5 — Flora Growth Corp. | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Flora Growth Corp. | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free